Delivery Order SPE2DR25D1205-SPE2DR26F0XT6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of OxyContin ER 40 mg tablets (100-count units) with a contract ceiling value of $8,112.79. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,438.70 for OxyContin ER 20 mg tablets (100-count) on December 10, 2025, with a completion date of December 11, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,315.52 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100 count) on November 12, 2025, with completion targeted for November 13, 2025. This firm fixed-price contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract is non-set-aside and was competitively awarded, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of OxyContin ER 30 mg tablets in quantities of 100 units, with a ceiling value of $1,045.05. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-competitive set-aside contract. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for OxyContin ER 30 mg tablets (100-count units) with a ceiling value of $1,717.40. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) with a ceiling value of $1,768.88. This non-competitive, firm fixed-price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is executed under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $4,901.31. This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, with no set-aside designation. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of OxyContin ER 10 mg tablets (100-count) valued at $3,143.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 7, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $2,098.96. This is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain, awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $1,796.20. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, representing a single-transaction purchase of pharmaceutical inventory. The contract was competitively awarded without set-aside designation, leveraging...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0XT6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units) with a ceiling value of $1,468.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 8, 2025, with performance based in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a critical role in the federal medical supply chain, particularly for Defense Health Agency and military healthcare systems. As a prime vendor for DLA's pharmaceutical procurement, the company supplies a broad range of medications and medical supplies through competitively awarded contracts with firm fixed pricing. This specific delivery order for controlled pain management pharmaceuticals reflects the company's established capability to fulfill federal medical procurement requirements across diverse therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/4/25 |